540 related articles for article (PubMed ID: 36569912)
41. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies.
Collet R; Caballero-Ávila M; Querol L
Rev Neurol (Paris); 2023 Oct; 179(8):831-843. PubMed ID: 36907709
[TBL] [Abstract][Full Text] [Related]
42. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis.
Mausberg AK; Szepanowski F; Odoardi F; Flügel A; Kleinschnitz C; Stettner M; Kieseier BC
J Neuroinflammation; 2018 Aug; 15(1):217. PubMed ID: 30068351
[TBL] [Abstract][Full Text] [Related]
43. Treatment of immune-mediated inflammatory neuropathies.
Hadden RD; Hughes RA
Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
[TBL] [Abstract][Full Text] [Related]
44. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
[TBL] [Abstract][Full Text] [Related]
45. Inflammatory neuropathies.
Whitesell J
Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
[TBL] [Abstract][Full Text] [Related]
46. Atypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy.
Yosha-Orpaz N; Aharoni S; Rabie M; Nevo Y
J Child Neurol; 2019 Apr; 34(5):268-276. PubMed ID: 30674221
[TBL] [Abstract][Full Text] [Related]
47. The pathogenic relevance of α
Dong C; Palladino SP; Helton ES; Ubogu EE
Acta Neuropathol; 2016 Nov; 132(5):739-752. PubMed ID: 27460017
[TBL] [Abstract][Full Text] [Related]
48. Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome.
Previtali SC; Archelos JJ; Hartung HP
Ann Neurol; 1998 Oct; 44(4):611-21. PubMed ID: 9778259
[TBL] [Abstract][Full Text] [Related]
49. Dysregulation of lncRNAs in autoimmune neuropathies.
Gholipour M; Taheri M; Mehvari Habibabadi J; Nazer N; Sayad A; Ghafouri-Fard S
Sci Rep; 2021 Aug; 11(1):16061. PubMed ID: 34373511
[TBL] [Abstract][Full Text] [Related]
50. Treatment of Guillain-Barré syndrome and CIDP.
van Doorn PA
J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
[TBL] [Abstract][Full Text] [Related]
51. Immune reactions to P2 protein in human inflammatory demyelinative neuropathies.
Zweiman B; Rostami A; Lisak RP; Moskovitz AR; Pleasure DE
Neurology; 1983 Feb; 33(2):234-7. PubMed ID: 6600513
[TBL] [Abstract][Full Text] [Related]
52. Animal models for autoimmune demyelinating disorders of the nervous system.
Gold R; Hartung HP; Toyka KV
Mol Med Today; 2000 Feb; 6(2):88-91. PubMed ID: 10652482
[TBL] [Abstract][Full Text] [Related]
53. Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.
Fan C; Jin H; Hao H; Gao F; Sun Y; Lu Y; Liu Y; Lv P; Cui W; Teng Y; Huang Y
Muscle Nerve; 2017 Apr; 55(4):470-475. PubMed ID: 27464289
[TBL] [Abstract][Full Text] [Related]
54. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
Devaux JJ
Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
[TBL] [Abstract][Full Text] [Related]
55. T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome.
Hartung HP; Toyka KV
Ann Neurol; 1990; 27 Suppl():S57-63. PubMed ID: 2194429
[TBL] [Abstract][Full Text] [Related]
56. Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?
Wang Y; Zhang J; Luo P; Zhu J; Feng J; Zhang HL
Expert Opin Ther Targets; 2017 Jan; 21(1):103-112. PubMed ID: 27817222
[TBL] [Abstract][Full Text] [Related]
57. Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
Csurhes PA; Sullivan AA; Green K; Greer JM; Pender MP; McCombe PA
J Clin Neurosci; 2005 May; 12(4):409-15. PubMed ID: 15925771
[TBL] [Abstract][Full Text] [Related]
58. The spectrum of acquired demyelinating polyradiculoneuropathy.
Hughes RA
Acta Neurol Belg; 1994; 94(2):128-32. PubMed ID: 8036880
[TBL] [Abstract][Full Text] [Related]
59. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis].
Hartung HP; Heininger K; Toyka KV
Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228
[TBL] [Abstract][Full Text] [Related]
60. Recurrences, vaccinations and long-term symptoms in GBS and CIDP.
Kuitwaard K; Bos-Eyssen ME; Blomkwist-Markens PH; van Doorn PA
J Peripher Nerv Syst; 2009 Dec; 14(4):310-5. PubMed ID: 20021573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
